Phoenicis
Deborah Ramsdell is currently the Strategic Consultant at OcuCell and the Co-founder and CEO/COO at Phoenicis Therapeutics, a clinical stage startup biotechnology company specializing in rare dermatological disorders. Deborah also serves as the Owner of CMS International, Inc. and has held various executive positions in companies such as Valerion Therapeutics, Alopexx Enterprises, and Alexion Pharmaceuticals. With a strong background in regulatory affairs and clinical operations, Ramsdell brings extensive experience in the healthcare industry to their roles.
This person is not in any offices
Phoenicis
Phoenicis focuses on developing therapies to provide hope and relief to people living with rare disease.